Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,325

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update

Open access
Dworkin, Robert H., O'Connor, Alec B., Audette, Joseph, Baron, Ralf, Gourlay, Geoffrey K., Haanpää, Maija L., Kent, Joel L., Krane, Elliot J., LeBel, Alyssa A., Levy, Robert M., Mackey, Sean C., Mayer, John, Miaskowski, Christine, Raja, Srinivasa N., Rice, Andrew S.C., Schmader, Kenneth E., Stacey, Brett, Stanos, Steven, Treede, Rolf-Detlef, Turk, Dennis C., Walco, Gary A., Wells, Christopher D.·2010·Mayo Clinic Proceedings
DOI 10.4065/mcp.2009.0649
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4065/mcp.2009.0649

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 95

  1. Treede, 2008, Neuropathic pain: redefinition and a grading system for clinical research purposes, Neurology, 70, 1630, 10.1212/01.wnl.0000282763.29778.59 · DOI
  2. Oster, 2005, Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey, J Pain, 6, 356, 10.1016/j.jpain.2005.01.359 · DOI
  3. Gore, 2006, Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives, J Pain, 7, 892, 10.1016/j.jpain.2006.04.013 · DOI · Paper page
  4. McDermott, 2006, The burden of neuropathic pain: results of a cross-sectional survey, Eur J Pain, 10, 127, 10.1016/j.ejpain.2005.01.014 · DOI · Paper page
  5. Jensen, 2007, The impact of neuropathic pain on health-related quality of life: review and implications, Neurology, 68, 1178, 10.1212/01.wnl.0000259085.61898.9e · DOI · Paper page
  6. O'Connor, 2009, Neuropathic pain: a review of the quality of life impact, costs, and cost-effectiveness of therapy, Pharmacoeconomics, 27, 95, 10.2165/00019053-200927020-00002 · DOI
  7. Berger, 2004, Clinical characteristics and economic costs of patients with painful neuropathic disorders, J Pain, 5, 143, 10.1016/j.jpain.2003.12.004 · DOI · Paper page
  8. Dworkin, 2007, Health care costs of acute and chronic pain associated with a diagnosis of herpes zoster, J Am Geriatr Soc, 55, 1168, 10.1111/j.1532-5415.2007.01231.x · DOI
  9. Dworkin RH, Malone DC, Panarites CJ, Armstrong EP, Pham SV. Impact of postherpetic neuralgia and painful diabetic peripheral neuropathy on health care costs [published online ahead of print October 21, 2009]. J Pain. doi:10.1016/j.jpain. 2009.08.005. · doi:10.1016/j.jpain.2009.01.075
  10. van Hoek, 2009, Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales, Vaccine, 27, 1454, 10.1016/j.vaccine.2008.12.024 · DOI
  11. Attal, 2006, EFNS guidelines on pharmacological treatment of neuropathic pain, Eur J Neurol, 13, 1153, 10.1111/j.1468-1331.2006.01511.x · DOI · Paper page
  12. Moulin, 2007, Pharmacological management of chronic neuropathic pain—consensus statement and guidelines from the Canadian Pain Society, Pain Res Manag, 12, 13, 10.1155/2007/730785 · DOI · Paper page
  13. Attal, 2008, Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion?, Pain, 138, 343, 10.1016/j.pain.2008.01.006 · DOI · Paper page
  14. Baron, 2009, A cross sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory systems, Pain, 146, 34, 10.1016/j.pain.2009.06.001 · DOI · Paper page
  15. Gronseth, 2008, Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies, Neurology, 71, 1183, 10.1212/01.wnl.0000326598.83183.04 · DOI · Paper page
  16. Finnerup, 2005, Algorithm for neuropathic pain treatment: an evidence based proposal, Pain, 118, 289, 10.1016/j.pain.2005.08.013 · DOI · Paper page
  17. Max, 1987, Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood, Neurology, 37, 589, 10.1212/WNL.37.4.589 · DOI · Paper page
  18. Raskin, 2006, Duloxetine versus routine care in the long-term management of diabetic peripheral neuropathic pain, J Palliat Med, 9, 29, 10.1089/jpm.2006.9.29 · DOI
  19. Wernicke, 2007, An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies, Drug Saf, 30, 437, 10.2165/00002018-200730050-00007 · DOI
  20. McIntyre, 2008, The hepatic safety profile of duloxetine: a review, Expert Opin Drug Metab Toxicol, 4, 281, 10.1517/17425255.4.3.281 · DOI
  21. Rowbotham, 2004, Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study, Pain, 110, 697, 10.1016/j.pain.2004.05.010 · DOI · Paper page
  22. Fava, 1997, Emergence of adverse events following discontinuation of treatment with extended-release venlafaxine, Am J Psychiatry, 154, 1760, 10.1176/ajp.154.12.1760 · DOI · Paper page
  23. Stacey, 2008, Pregabalin for postherpetic neuralgia: placebo-controlled trial of fixed and flexible dosing regimens on allodynia and time to onset of pain relief, J Pain, 9, 1006, 10.1016/j.jpain.2008.05.014 · DOI
  24. Wasner, 2005, Postherpetic neuralgia: topical lidocaine is effective in nociceptor-deprived skin, J Neurol, 252, 677, 10.1007/s00415-005-0717-z · DOI
  25. Herrmann, 2006, Skin biopsy and quantitative sensory testing do not predict response to the lidocaine patch in painful neuropathies, Muscle Nerve, 33, 42, 10.1002/mus.20419 · DOI
  26. Wu, 2008, Morphine versus mexiletine for treatment of postamputation pain, Anesthesiology, 109, 289, 10.1097/ALN.0b013e31817f4523 · DOI
  27. Raja, 2002, Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial, Neurology, 59, 1015, 10.1212/WNL.59.7.1015 · DOI · Paper page
  28. Chou, 2009, Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain, J Pain, 10, 113, 10.1016/j.jpain.2008.10.008 · DOI · Paper page
  29. Katz, 2008, Clinical trial outcome in neuropathic pain: relationship to study characteristics, Neurology, 70, 263, 10.1212/01.wnl.0000275528.01263.6c · DOI · Paper page
  30. Vranken, 2008, Pregabalin in patients with central neuropathic pain: a randomized, double-blind, placebo-controlled trial of a flexible-dose regimen, Pain, 136, 150, 10.1016/j.pain.2007.06.033 · DOI · Paper page
  31. Norrbrink, 2009, Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial, Clin J Pain, 25, 177, 10.1097/AJP.0b013e31818a744d · DOI
  32. O'Connor, 2008, Pain associated with multiple sclerosis: systematic review and proposed classification, Pain, 137, 96, 10.1016/j.pain.2007.08.024 · DOI · Paper page
  33. Rice, 2008, Should cannabinoids be used as analgesics for neuropathic pain?, Nat Clin Pract Neurol, 4, 654, 10.1038/ncpneuro0949 · DOI
  34. Tugnoli, 2007, Botulinum toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin, Pain, 130, 76, 10.1016/j.pain.2006.10.030 · DOI
  35. Ranoux, 2008, Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain, Ann Neurol, 64, 274, 10.1002/ana.21427 · DOI · Paper page
  36. Yuan, 2009, Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial, Neurology, 72, 1473, 10.1212/01.wnl.0000345968.05959.cf · DOI · Paper page
  37. Backonja, 2008, NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study, Lancet Neurol, 7, 1106, 10.1016/S1474-4422(08)70228-X · DOI · Paper page
  38. Simpson, 2008, Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy, Neurology, 70, 2305, 10.1212/01.wnl.0000314647.35825.9c · DOI · Paper page
  39. Polydefkis, 2004, The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy, Brain, 127, 1606, 10.1093/brain/awh175 · DOI · Paper page
  40. Magerl, 2001, Roles of capsaicin-in-sensitive nociceptors in cutaneous pain and secondary hyperalgesia, Brain, 124, 1754, 10.1093/brain/124.9.1754 · DOI · Paper page
  41. Rauck, 2007, Lacosamide in painful diabetic peripheral neuropathy: a phase 2 double-blind placebo-controlled study, Clin J Pain, 23, 150, 10.1097/01.ajp.0000210957.39621.b2 · DOI
  42. Shaibani, 2009, Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial, J Pain, 10, 818, 10.1016/j.jpain.2009.01.322 · DOI
  43. Wymer, 2009, Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens, Clin J Pain, 25, 376, 10.1097/AJP.0b013e318196d2b6 · DOI
  44. Hidvégi T, Bretschneider B, Thierfelder S, Sommerville K, Bongardt S. Long-term efficacy of lacosamide in subjects with diabetic neuropathic pain: results of a double-blind, randomized withdrawal trial. Presented at: 27th annual meeting of the American Pain Society; Tampa, FL; May 8-10, 2008. · doi:10.1016/j.jpain.2008.01.125
  45. O'Connor, 2009, The need for improved access to FDA reviews, JAMA, 302, 191, 10.1001/jama.2009.973 · DOI
  46. Shaibani, 2009, Long-term oral lacosamide in painful diabetic neuropathy: a two-year open-label extension trial, Eur J Pain, 13, 458, 10.1016/j.ejpain.2008.05.016 · DOI
  47. Sindrup, 1990, The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms, Pain, 42, 135, 10.1016/0304-3959(90)91157-E · DOI · Paper page
  48. Sindrup, 1992, The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy, Clin Pharmacol Ther, 52, 547, 10.1038/clpt.1992.183 · DOI · Paper page
  49. Max, 1992, Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy, N Engl J Med, 326, 1250, 10.1056/NEJM199205073261904 · DOI · Paper page
  50. Otto, 2008, Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial, Pain, 139, 275, 10.1016/j.pain.2008.04.012 · DOI
  51. Gilron, 2005, Morphine, gabapentin, or their combination for neuropathic pain, N Engl J Med, 352, 1324, 10.1056/NEJMoa042580 · DOI · Paper page
  52. Hanna, 2008, Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients, Eur J Pain, 12, 804, 10.1016/j.ejpain.2007.12.010 · DOI · Paper page
  53. Zin CS, Nissen LM, O'Callaghan JP, Duffull SB, Smith MT, Moore BJ. A randomized controlled trial of oxycodone vs placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin [published online ahead of print December 2, 2009]. J Pain. doi:10.1016/j. jpain.2009.09.003. · doi:10.1016/j
  54. Gatti, 2009, Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study, Eur Neurol, 61, 129, 10.1159/000186502 · DOI
  55. Gilron, 2009, Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial, Lancet, 374, 1252, 10.1016/S0140-6736(09)61081-3 · DOI · Paper page
  56. Baron, 2009, Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy, Curr Med Res Opin, 25, 1677, 10.1185/03007990903048078 · DOI
  57. Agrawal, 2009, Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study, Diabetes Res Clin Pract, 83, 371, 10.1016/j.diabres.2008.12.018 · DOI
  58. Dworkin, 2008, Randomized clinical trials of pregabalin for neuropathic pain: methods, results, and implications, Progr Neurotherapeutics Neuropsychopharmacol, 3, 167, 10.1017/S1748232107000080 · DOI
  59. Khoromi, 2007, Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain, Pain, 130, 66, 10.1016/j.pain.2006.10.029 · DOI · Paper page
  60. Thienel, 2004, Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials, Acta Neurol Scand, 110, 221, 10.1111/j.1600-0404.2004.00338.x · DOI · Paper page
  61. Beydoun, 2006, Oxcarbazepine in painful diabetic neuropathy: results of a dose-ranging study, Acta Neurol Scand, 113, 395, 10.1111/j.1600-0404.2006.00631.x · DOI
  62. Breuer, 2007, A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis, Clin Ther, 29, 2022, 10.1016/j.clinthera.2007.09.023 · DOI
  63. Silver, 2007, Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain, J Pain Symptom Manage, 34, 446, 10.1016/j.jpainsymman.2006.12.015 · DOI
  64. Vinik, 2007, Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized double-blind, placebo-controlled studies, Pain, 128, 169, 10.1016/j.pain.2006.09.040 · DOI · Paper page
  65. Rice, 2008, Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards, Pain, 139, 243, 10.1016/j.pain.2008.08.017 · DOI · Paper page
  66. Hansson, 2005, Pharmacological treatment of peripheral neuropathic conditions based on shared commonalities despite multiple etiologies, Pain, 113, 251, 10.1016/j.pain.2004.10.007 · DOI
  67. Kieburtz, 1998, A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection, Neurology, 51, 1682, 10.1212/WNL.51.6.1682 · DOI
  68. Shlay, 1998, Acupuncture and amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial, JAMA, 280, 1590, 10.1001/jama.280.18.1590 · DOI · Paper page
  69. Estanislao, 2004, A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy, J Acquir Immune Defic Syndr, 37, 1584, 10.1097/00126334-200412150-00010 · DOI
  70. Schifitto, 2006, A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy, J Neurovirol, 12, 328, 10.1080/13550280600873835 · DOI
  71. Hammack, 2002, Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy, Pain, 98, 195, 10.1016/S0304-3959(02)00047-7 · DOI · Paper page
  72. Kautio, 2008, Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms, J Pain Symptom Manage, 35, 31, 10.1016/j.jpainsymman.2007.02.043 · DOI · Paper page
  73. Rao, 2007, Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3), Cancer, 110, 2110, 10.1002/cncr.23008 · DOI · Paper page
  74. Khoromi, 2005, Topiramate in chronic lumbar radicular pain, J Pain, 6, 829, 10.1016/j.jpain.2005.08.002 · DOI · Paper page
  75. Cruccu, 2007, EFNS guidelines on neurostimulation therapy for neuropathic pain, Eur J Neurol, 14, 952, 10.1111/j.1468-1331.2007.01916.x · DOI · Paper page
  76. Raskin, 2004, Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects, Neurology, 63, 865, 10.1212/01.WNL.0000137341.89781.14 · DOI
  77. Dworkin, 2005, Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain, Neurology, 65, S7
  78. Katz, 2005, Methodological issues in clinical trials of opioids for chronic pain, Neurology, 65, S32
  79. Quessy, 2008, Placebo response in neuropathic pain trials, Pain, 138, 479, 10.1016/j.pain.2008.06.024 · DOI
  80. Katz, 2009, Enriched enrollment randomized withdrawal trial designs for analgesics, Clin J Pain, 25, 797, 10.1097/AJP.0b013e3181b12dec · DOI
  81. Dworkin, 2009, Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations, Pain, 146, 238, 10.1016/j.pain.2009.08.019 · DOI · Paper page
  82. Morello, 1999, Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic neuropathy pain, Arch Intern Med, 159, 1931, 10.1001/archinte.159.16.1931 · DOI · Paper page
  83. Chandra, 2006, Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial—the GONIP trial, Int J Clin Pharmacol Ther, 44, 358, 10.5414/CPP44358 · DOI
  84. Baron, 2009, Efficacy and safety of 5% lidocaine (lignocaine) medicated plaster in comparison with pregabalin in patients with postherpetic neuralgia and diabetic polyneuropathy: interim analysis from an open-label, two-stage adaptive, randomized, controlled trial, Clin Drug Investig, 29, 231, 10.2165/00044011-200929040-00002 · DOI
  85. Baron, 2009, 5% Lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study, Curr Med Res Opin, 25, 1663, 10.1185/03007990903047880 · DOI · Paper page
  86. Rintala, 2007, Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury, Arch Phys Med Rehabil, 88, 1547, 10.1016/j.apmr.2007.07.038 · DOI · Paper page
  87. Hansson, 2009, Toward a definition of pharmacoresistant neuropathic pain, Eur J Pain, 13, 439, 10.1016/j.ejpain.2009.02.008 · DOI
  88. Kehlet, 2006, Persistent postsurgical pain: risk factors and prevention, Lancet, 367, 1618, 10.1016/S0140-6736(06)68700-X · DOI · Paper page
  89. Woolf, 2004, Pain: moving from symptom control toward mechanism-specific pharmacologic management, Ann Intern Med, 140, 441, 10.7326/0003-4819-140-8-200404200-00010 · DOI · Paper page
  90. Rowbotham, 2005, Mechanisms of neuropathic pain and their implications for the design of clinical trials, Neurology, 65, S66
  91. Hansson, 2003, Difficulties in stratifying neuropathic pain by mechanisms, Eur J Pain, 7, 353, 10.1016/S1090-3801(03)00051-X · DOI
  92. Rolke, 2006, Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values, Pain, 123, 231, 10.1016/j.pain.2006.01.041 · DOI · Paper page
  93. Rolke, 2006, Quantitative sensory testing: a comprehensive protocol for clinical trials, Eur J Pain, 10, 77, 10.1016/j.ejpain.2005.02.003 · DOI · Paper page
  94. Scholz, 2009, A novel tool for the assessment of pain: validation in low back pain, PLoS Med, 6, e1000047, 10.1371/journal.pmed.1000047 · DOI · Paper page
  95. Turk, 1990, Customizing treatment for chronic pain patients: who, what and why?, Clin J Pain, 6, 255, 10.1097/00002508-199012000-00002 · DOI · Paper page

Cited by

See all 1,325

Metadata

Authors
Dworkin, R. H., O'Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., LeBel, A. A., Levy, R. M., Mackey, S. C., Mayer, J., Miaskowski, C., Raja, S. N., Rice, A. S. C., Schmader, K. E., Stacey, B., Stanos, S., Treede, R.-D., Turk, D. C., Walco, G. A., & Wells, C. D.
Venue
Mayo Clinic Proceedings
Publisher
Elsevier BV
Published
2010-03
Volume
85
Issue
3
Pages
S3-S14
ISSN
0025-6196 (ISSN-L)
DOI
10.4065/mcp.2009.0649
OpenAlex
W2084567915
Cited by
1,325
References
8
FWCI
67.53
Type
journal article
Language
en
Open access
bronze
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update. https://app.cochat.ai/papers/10.4065/mcp.2009.0649
The paper
Dworkin, R. H., O'Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., LeBel, A. A., Levy, R. M., Mackey, S. C., Mayer, J., Miaskowski, C., Raja, S. N., Rice, A. S. C., Schmader, K. E., Stacey, B., Stanos, S., Treede, R.-D., . . . Wells, C. D. (2010). Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update. Mayo Clinic Proceedings. https://doi.org/10.4065/mcp.2009.0649

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.